David Krempa | executive |
Sean Brynjelsen | executive |
James Gruber | executive |
Chase Knickerbocker | analyst |
Good afternoon, and welcome to the Eton Pharmaceuticals First Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request. At this time, I would like to turn it over to David Krempa, Chief Business Officer at Eton Pharmaceuticals. Please proceed.
Thank you, operator.